The weight-loss results at 48-weeks with the 12 mg (higher dose) retatrutide group achieved a mean weight reduction of -24.2%, while the placebo group only saw a -2.1% change
Future research should examine whether sharing about ones concurrent lifestyle change efforts can buffer stigma faced by GLP-1 users
Most plans evaluate these medications on a case-by-case basis
Accessing Zepbound Through Medicare Part D Patients interested in Zepbound should take the following steps: Consult with a healthcare provider to determine if Zepbound is appropriate for their condition
Wegovy, Mounjaro, and Zepbound are supplied as single-use prefilled pens (though in some cases, other forms, such as single-dose vials, may be available directly from the manufacturer)
This takes ten seconds per injection and creates a record that can be invaluable if you ever need to troubleshoot a color change, a loss of efficacy, or an unexpected side effect